Net Income (TTM) Chart

View Net Income (TTM) for BNTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (TTM) Chart
Start Trial

Historical Net Income (TTM) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -1.965B
March 31, 2026 -1.449B
December 31, 2025 -1.264B
September 30, 2025 -632.54M
June 30, 2025 -381.38M
March 31, 2025 -812.81M
December 31, 2024 -717.19M
September 30, 2024 -501.56M
June 30, 2024 -544.48M
March 31, 2024 117.93M
December 31, 2023 998.75M
September 30, 2023 2.831B
Date Value
June 30, 2023 4.453B
March 31, 2023 6.440B
December 31, 2022 10.05B
September 30, 2022 11.34B
June 30, 2022 13.33B
March 31, 2022 14.91B
December 31, 2021 12.12B
September 30, 2021 8.941B
June 30, 2021 4.911B
March 31, 2021 1.453B
December 31, 2020 35.89M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (TTM) Range, Past 5 Years

View Net Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (TTM) Benchmarks

View Net Income (TTM) Benchmarks
Start Trial
Moderna, Inc. -3.151B
Biodexa Pharmaceuticals Plc -8.387M
NuCana Plc -13.03M
Mereo BioPharma Group Plc -28.05M
MediGene AG --